SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsLowNeutral
Announced Wed, 6 Aug · 11:18 IST

Shilpa Medicare Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shilpa Medicare has informed the exchanges that it will announce its Q1 FY2025-26 results (for the quarter ended June 30, 2025) on Wednesday, August 13, 2025. Right after the results, the company's management will host an earnings conference call at 5:00 PM on the same day to discuss performance with analysts and investors. The company has shared dial-in numbers for participants from India, USA, UK, Singapore, and Hong Kong, along with a DiamondPass link for priority joining. This is a routine regulatory disclosure made under SEBI listing rules. Shilpa Medicare is an integrated pharma company with businesses in oncology APIs, peptides, polymers, formulations, and CDMO services.

Likely market impact

No direct financial impact on shareholders — this is a scheduling update for an upcoming results announcement and earnings call. Investors should watch the August 13 results and management commentary for insights into Q1 performance and outlook, which could influence short-term stock sentiment.